Exact Sciences Corporation
NASDAQ:EXAS
65.54 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Exact Sciences Corporation |
Symbool | EXAS |
Munteenheid | USD |
Prijs | 65.54 |
Beurswaarde | 12,109,825,800 |
Dividendpercentage | 0% |
52-weken bereik | 40.62 - 79.62 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Kevin T. Conroy |
Website | https://www.exactsciences.com |
An error occurred while fetching data.
Over Exact Sciences Corporation
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)